Latest Strategy Changes News

Helios Energy Ltd has secured A$691,325 through interest-free Convertible Notes to advance its Presidio Project in Texas, ensuring regulatory compliance and operational continuity.

The Australian Office of Financial Management has issued a new 4.25% Treasury Bond due in 2036, set to begin trading on the ASX from February 13, 2025. This issuance adds a fresh long-term government debt instrument to the market.

Neuren Pharmaceuticals has received a significant cash inflow of approximately US$50 million following the sale of a Priority Review Voucher linked to its Rett syndrome treatment. This milestone underscores the growing value of Neuren’s neurological drug portfolio and its partnership with Acadia Pharmaceuticals.

Sigma Healthcare has raised its FY25 normalised EBIT guidance to $64-$70 million, driven by robust operational performance and the successful rollout of a key supply contract with Chemist Warehouse.

Hartshead Resources has submitted a development programme and budget to the P2607 Joint Venture, proposing a new gas export route through CalEnergy’s Saturn Banks pipeline, promising reduced capital expenditure and accelerated production timelines.

Pact Group Holdings has responded to an ASX price query, confirming no undisclosed material information and previewing a modest earnings uplift for the half-year ending December 2024.

Cyprium Metals has successfully closed its pro rata non-renounceable entitlement offer, raising A$1.53 million with a 51% shareholder participation rate. The company plans to issue over 54 million new shares, while retaining discretion over a significant shortfall.

Tivan has initiated its first diamond drilling program at the high-grade lead-silver Aileron target in the Northern Territory, following a key land access agreement. This marks a pivotal step in assessing a promising polymetallic deposit within the Sandover AI Project.

Invex Therapeutics reports a significant reduction in net loss for H1 FY2025 alongside promising pre-clinical data for Exenatide in Alzheimer’s Disease models.

PARKD has inked a pivotal five-year exclusive licensing agreement with Fielders, a BlueScope Steel division, to commercialise its innovative MDSB® and MDSS® products in Australia and explore international expansion.

Whitebark Energy has identified promising hydrogen and hydrocarbon emission hotspots at King Energy’s Alinya Project in South Australia, following a detailed multispectral remote sensing study. These findings set the stage for targeted in-field testing and exploration drilling planned for later in 2025.

Spacetalk Ltd has secured a $428,853 R&D tax rebate from the Australian Taxation Office, reinforcing its commitment to innovation while reporting a 16% increase in Annual Recurring Revenue and significant cost reductions.